A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/56 (2006.01) A61K 31/585 (2006.01)
Patent
CA 2495376
The present invention is directed to a method for preventing an increase in matrix metalloproteinase (MMP) activity or reducing MMP activity in a subject in need thereof by administering to the subject a therapeutically effective amount of a selective aldosterone blocker. More particularly, the present invention is directed to attenuating or preventing an increase in MMP activity comprising administering eplerenone, or derivatives thereof.
L'invention concerne un procédé permettant d'empêcher une augmentation de l'activité de la métalloprotéinase matricielle (MMP) ou de réduire une telle activité chez un patient qui en a besoin par administration audit patient d'une dose thérapeutiquement efficace d'un anti-aldostérone sélectif. Plus précisément, l'invention concerne l'atténuation ou la prévention d'une augmentation de l'activité de MMP consistant à administrer l'éplérénone ou des dérivés de celui-ci.
Mcmahon Ellen G.
Rudolph Amy E.
Gowling Lafleur Henderson Llp
Mcmahon Ellen G.
Pharmacia Corporation
Rudolph Amy E.
LandOfFree
Modulation of matrix metalloproteinase (mmp) activity with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of matrix metalloproteinase (mmp) activity with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of matrix metalloproteinase (mmp) activity with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1686476